Galcanezumab-Gnlm
3 NDCs across 1 manufacturer|0 Generic,3 Brand
Galcanezumab-Gnlm is used to treat cluster headache, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
In 2024, Medicare Part D spent $305 million on Galcanezumab-Gnlm across 349,000 claims for 61,000 beneficiaries.
Galcanezumab-Gnlm is available as 3 NDCs from 1 manufacturer (0 generic, 3 brand), with NADAC prices from $612.52 to $734.42 per ML — a 20% difference between cheapest and most expensive. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
3
0G / 3B
Manufacturers
1
competing in market
Price Spread
$612.52 – $734.42
per ML
7d Activity
avg +0.0% WoW · of 3 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Eli Lilly and Company manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing GALCANEZUMAB-GNLM
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
EMGALITY 120 MG/ML SYRINGE | $734.4208 per ML | -0.01% |
EMGALITY 120 MG/ML PEN | $734.2833 per ML | +0.01% |
EMGALITY 300 MG DOSE (100 MG/ML X 3 SYRINGES) | $612.5164 per ML | -0.01% |
Frequently Asked Questions
What is Galcanezumab-Gnlm used to treat?
Galcanezumab-Gnlm is used to treat cluster headache, per the National Library of Medicine's MED-RT classification.
How much does Medicare spend on Galcanezumab-Gnlm?
In 2024, Medicare Part D spent $305 million on Galcanezumab-Gnlm across 349,000 claims for 61,000 beneficiaries.
How many Galcanezumab-Gnlm products are on the market?
The Galcanezumab-Gnlm drug market contains 3 NDCs from 1 manufacturer — 0 generic and 3 brand products.
What is the price range for Galcanezumab-Gnlm?
NADAC reference prices for Galcanezumab-Gnlm range from $612.5164 to $734.4208 per ML — a 20% difference between cheapest and most expensive.
Which manufacturers make Galcanezumab-Gnlm?
1 manufacturer lists Galcanezumab-Gnlm in NADAC. Ranked by number of NDCs, the largest are Eli Lilly and Company (3).
How has the price of Galcanezumab-Gnlm changed recently?
Over the past 7 days, 1 Galcanezumab-Gnlm NDC rose and 2 fell, with a market-wide average change of +0.0%.